Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

728
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
728
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

981
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
981
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

791
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
791
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

490
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
490
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

421
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
421
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

407
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
407

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ozzy Osbourne and Parkinson's disease: from darkness to awareness.

Arquivos de neuro-psiquiatria·2026
Same author

Longitudinally extensive myelitis in neurosarcoidosis.

Practical neurology·2026
Same author

SCA27B in Brazil: frequency, phenotype and genotype-phenotype correlations.

Journal of neurology·2026
Same author

Adult-onset spontaneous periodic hypothermia with hyperhidrosis: three cases of a Shapiro syndrome variant.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2026
Same author

Reply to: "Drinking-Induced Orolingual Tremor: Report of Two Cases with a Novel Response to Propranolol".

Movement disorders clinical practice·2026
Same author

Arts Syndrome and Involuntary Eye Movements.

Movement disorders clinical practice·2026

Related Experiment Video

Updated: Jan 8, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

12.1K

Respiratory Function in Friedreich's Ataxia.

Celiana Figueiredo Viana1, Cristina Saade Jaques1, Marcio Luiz Escorcio Bezerra1

  • 1Division of General Neurology and Ataxia Unit, Department of Neurology, Universidade Federal de São Paulo-Escola Paulista de Medicina, São Paulo, Brazil.

Movement Disorders : Official Journal of the Movement Disorder Society
|December 19, 2025
PubMed
Summary
This summary is machine-generated.

Friedreich's ataxia (FA) patients show reduced lung function and respiratory muscle strength, indicating subclinical respiratory impairment. Early assessment and intervention are crucial for managing pulmonary issues in FA.

Keywords:
Friedreich's ataxiadysphagiaphrenic nerve conductionrespiratory parametersspirometry

More Related Videos

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
09:24

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease

Published on: April 17, 2017

13.5K
Functional and Morphological Assessment of Diaphragm Innervation by Phrenic Motor Neurons
09:43

Functional and Morphological Assessment of Diaphragm Innervation by Phrenic Motor Neurons

Published on: May 25, 2015

18.1K

Related Experiment Videos

Last Updated: Jan 8, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

12.1K
Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
09:24

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease

Published on: April 17, 2017

13.5K
Functional and Morphological Assessment of Diaphragm Innervation by Phrenic Motor Neurons
09:43

Functional and Morphological Assessment of Diaphragm Innervation by Phrenic Motor Neurons

Published on: May 25, 2015

18.1K

Area of Science:

  • Neurology
  • Pulmonology
  • Genetics

Background:

  • Friedreich's ataxia (FA) is a rare neurodegenerative disorder.
  • Respiratory dysfunction is a common but understudied complication in FA patients.

Purpose of the Study:

  • To comprehensively evaluate pulmonary function and respiratory muscle strength in individuals with FA.
  • To compare respiratory parameters between FA patients and healthy controls.

Main Methods:

  • Sixteen FA patients and 20 healthy controls underwent spirometry, maximal respiratory pressure measurements, sniff nasal inspiratory pressure (SNIP), phrenic nerve conduction study, SpO2, and ETCO2.
  • Statistical analysis included t-tests, Mann-Whitney tests, and regression models adjusted for BMI and smoking status.
  • Ataxia severity was quantified using the Scale for the Assessment and Rating of Ataxia (SARA).

Main Results:

  • FA patients demonstrated significantly reduced forced vital capacity (FVC) and forced expiratory volume in 1s (FEV1).
  • Decreased maximal respiratory pressures and a predominant restrictive ventilatory pattern were observed in the FA group.
  • Lower peripheral oxygen saturation (SpO2) was noted in FA patients compared to controls.

Conclusions:

  • Respiratory impairment in FA is often subclinical, posing risks for pulmonary infections and ventilatory failure.
  • Neuromuscular weakness and impaired respiratory coordination likely contribute to the observed dysfunction.
  • Regular respiratory assessments and integrated multidisciplinary care are recommended to improve outcomes in FA.